‌

US Patent 11970544 Antibodies

Patent 11970544 was granted and assigned to Genmab A/S on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Paul Parren0

Sjeng Horbach0

Dennis Verzijl0

Patrick Engelberts0

Rik Rademaker0

Bart E. C. G. De Goeij0

David Satijn0

Edward N. Van Den Brink0

...

Date of Patent

April 30, 2024

0

Patent Application Number

173530870

Date Filed

June 21, 2021

0

Patent Citations

US Patent 10465006 Humanized or chimeric CD3 antibodies

0

US Patent 10590206 Inert format

0

US Patent 10597464 Heterodimeric antibody Fc-containing proteins and methods for production thereof

0

US Patent 10906991 Bispecific antibodies and methods for production thereof

0

US Patent 11130819 Antibodies

0

US Patent 11008399 Antibodies

0

US Patent 9150663 Heterodimeric antibody Fc-containing proteins and methods for production thereof

0

US Patent 9212230 Bispecific antibodies and methods for production thereof

0

...

Patent Primary Examiner

Jessica H Roark

0

Patent abstract

The present invention relates to antibodies binding to 5T4, including bispecific antibodies binding to 5T4 and CD3. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11970544 Antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.